- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2334
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
New anti-HCV agents in the pipeline ; volume:14 ; number:2 ; day:23 ; month:5 ; year:2014 ; pages:1 ; date:5.2014
BMC infectious diseases ; 14, Heft 2 (23.5.2014), 1, 5.2014
- Creator
-
Zoulim, Fabien
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/1471-2334-14-S2-S15
- URN
-
urn:nbn:de:1111-2016030320914
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
2025-08-15T07:25:03+0200
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Zoulim, Fabien
- SpringerLink (Online service)
Other Objects (12)
New anti HCV drugs in the pipeline
Lysosomotropic agents as HCV entry inhibitors
Synthesis and biological evaluation of tricyclic matrinic derivatives as a class of novel anti-HCV agents
HCV and kidney transplant in the era of new direct-acting antiviral agents (DAAs)
New Hepatitis C Virus (HCV) Drugs and the Hope for a Cure: Concepts in Anti-HCV Drug Development
Untersuchung visueller Aufmerksamkeitsparameter vor und nach einer Hepatitis C (HCV)-Therapie mit Direct Antiviral Agents bei HCV-monoinfizierten und HCV/HIV-koinfizierten Patienten
Frequenz von Anti-HCV in einem internistischen Krankengut
Approaches to anti-viral agents
HCV
Anti-HCV-Prävalenz bei Leberkranken im Raum Halle/Saale
Enhanced anti-HCV activity of interferon alpha 17 subtype
HCV core antigen and HCV-RNA in HIV/HCV co-infected patients with different HCV genotypes
New anti HCV drugs in the pipeline
Lysosomotropic agents as HCV entry inhibitors
Synthesis and biological evaluation of tricyclic matrinic derivatives as a class of novel anti-HCV agents
HCV and kidney transplant in the era of new direct-acting antiviral agents (DAAs)
New Hepatitis C Virus (HCV) Drugs and the Hope for a Cure: Concepts in Anti-HCV Drug Development
Untersuchung visueller Aufmerksamkeitsparameter vor und nach einer Hepatitis C (HCV)-Therapie mit Direct Antiviral Agents bei HCV-monoinfizierten und HCV/HIV-koinfizierten Patienten
Frequenz von Anti-HCV in einem internistischen Krankengut
Approaches to anti-viral agents
HCV
Anti-HCV-Prävalenz bei Leberkranken im Raum Halle/Saale
Enhanced anti-HCV activity of interferon alpha 17 subtype
HCV core antigen and HCV-RNA in HIV/HCV co-infected patients with different HCV genotypes
New anti HCV drugs in the pipeline
Lysosomotropic agents as HCV entry inhibitors
Synthesis and biological evaluation of tricyclic matrinic derivatives as a class of novel anti-HCV agents
HCV and kidney transplant in the era of new direct-acting antiviral agents (DAAs)
New Hepatitis C Virus (HCV) Drugs and the Hope for a Cure: Concepts in Anti-HCV Drug Development
Untersuchung visueller Aufmerksamkeitsparameter vor und nach einer Hepatitis C (HCV)-Therapie mit Direct Antiviral Agents bei HCV-monoinfizierten und HCV/HIV-koinfizierten Patienten
Frequenz von Anti-HCV in einem internistischen Krankengut
Approaches to anti-viral agents
HCV
Anti-HCV-Prävalenz bei Leberkranken im Raum Halle/Saale
Enhanced anti-HCV activity of interferon alpha 17 subtype